This is a PE playbook. You are not in PE. So why are you reading it?
Because PE owns the platforms you compete with. PE may own the platform that acquires you. PE may already own you. In every one of those cases, someone two floors up is having this conversation about your function whether you are in the room or not.
You are the function. You are also the lever. The CX leader who can name the play in the language PE uses gets to run it. The CX leader who cannot will have it run on top of them.
This is that play.
The Contact Center Lever: a hybrid CX operating model, sequenced for PE
The lever is your contact center.
Most operating partners treat it as an ops detail. In this market, that is wrong.
- Labor is the dominant cost
- Fragmented inherited operations are the single largest unrealized synergy The hybrid labor + AI model compounds the savings into margin you can defend The play has a sequence. The sequence matters more than the technology choice.
The sequence
The conventional sequence in 2026 is AI first. Voice bots. Magic dashboards. The same vendor parade pitching every PE in healthcare.
Here’s the problem: AI deployed on a fragmented operation produces five versions of broken. The savings do not materialize. The investor narrative collapses on the next board cycle.
The contrarian sequence is consolidation first. Automation second.
Phase 1: Consolidate. One healthcare-experienced BPO partner. The acquired-location patchwork normalizes. Scripts standardize. Protocols standardize. Intake standardizes. Labor savings show up in months, not years..
Phase 2: Automate. Targeted AI on the consolidated operation. Intake routing. Agent assist. Outbound personalization. Automated QA across every call. The categories are real. They work because the operation is now standardized enough for AI to be most effective. Phase 1 funds Phase 2.
Phase 3: Compound. Tune the human-AI mix. Share KPIs across labor and tech. The margin compounds. The operation handed to the next owner is materially more valuable than the one acquired.
Most operating partners under-index on Phase 3. Exit multiples are a function of demonstrated operating performance, not just trailing financials. A platform with consolidated hybrid CX and clean metrics sells differently than a platform with patchwork front offices.
This play moves the exit multiple. You can own this play or be told to run the conventional one.
Why this fits PE specifically
This sequence was effectively built for the PE thesis environment, even though that was not the original intent.
It is self-funding. The CX Dream Path™ framework has labor optimization producing the savings that fund AI deployment. No fresh capital contribution. The play funds itself out of cost structure improvement you were already trying to capture.
It is fast. The Phase 1 labor consolidation is something the right BPO partner can stand up inside a quarter, not a year. . For a PE with hold-period pressure, that timeline matters.
It is defensible. The narrative is concrete:
- “We consolidated fragmented patient access across the platform.”
- “We captured the unrealized synergy.”
- “We redeployed the savings into automation that compounds the margin lift.”
That story maps to deal-model logic. It does not require anyone to take an AI vendor’s case study on faith.
It is force-multiplying. You are not asking your CEO to run a multi-vendor RFP across BPO and AI tech while still hitting the operating plan. The advisor runs that. The operating partner gets the consolidated recommendation, the savings model, and the implementation plan.
What you are actually missing
Here is the part most operating partners and portfolio CEOs aren’t telling you.
You already see the lever. You probably have a version of this play in mind, or at least the rough shape of it. What you do not have are the three strategic instruments to execute on it inside the hold.
Budget. Every phase requires spending. The board does not want the EBITDA drain from new monthly recurring costs.. The Phase 2 AI investment cannot get funded until Phase 1 produces savings, and Phase 1 itself requires the right BPO partnership decision.
Vision. Every BPO and AI vendor pitching the platform is selling their own roadmap. None of them sequences for the PE timeline. None of them is incentivized to give you the honest order of operations. So the play exists in fragments, owned by nobody in particular.
Risk reduction. A wrong BPO partner pick costs you time you cannot recover. Picking a partner with high agent attrition, weak healthcare experience, or a model that does not consolidate cleanly across acquired locations will erase the savings line you were planning to redeploy. This is the gap. Not knowledge. Strategic instruments. And it is exactly what a CX advisor brings into the room.
What advisory unlocks at each phase
In Phase 1, the work is to find the right BPO partner. We have evaluated 1,500+ BPO and CX technology providers across 100+ countries. The shortlist for a PE-backed specialty platform is small: healthcare-vetted, sized for your specific volume across the rolled-up locations, and filtered for partners with healthcare retention performance that will not undermine your savings. You do not have to run the RFP. We do. The operating partner gets a structured side-by-side comparison and a savings model in weeks, not quarters.
In Phase 2, the work is to identify the AI capabilities that actually fit the now-consolidated operation. Capability mapping. Vendor evaluation. Demo coordination. The same independence and rigor applied to the technology decision, with the same agnostic positioning relative to the AI vendor parade.
Across both phases, we stay engaged. KPIs get defined and tracked. Escalations get worked. Performance gets optimized. The advisory does not end at signature, because the operating lever does not stop at signature.
And here is the part that matters to a PE operating partner specifically. Outsource Consultants advisory comes at no cost to enterprise clients. There is no advisory fee to absorb into the deal economics. That is part of the model.
The proprietary part: the CX Dream Path™
The framework underneath all of this is our CX Dream Path™. Three stages. Save Money First. Deploy AI Risk-Free. Achieve Dream-State CX. It is a self-funding model designed for environments where new spend is hard to get approved.
For a PE-backed platform, this is the framework that converts the patient access lever into a defensible margin story, sequences the deployment for speed and risk mitigation, and compounds the operational improvement into a more valuable exit asset.
What changes for you
Budget gets unlocked. Phase 1 self-funds Phase 2. The narrative gets easier because the savings come first, the reinvestment proposal comes second, and no new investment is required.
Vision gets sharpened. The play stops living in fragments across vendor pitches. You have an advisor who has run this exact sequence in dozens of healthcare contexts and is paid by no one to recommend a particular vendor.
Risk gets reduced. Vendor selection runs through structured comparison, healthcare-specific vetting, and ongoing performance monitoring after signature. The expensive mistakes that would burn hold-period time get caught before they happen.
And then the thesis math changes.
The margin expansion shows up.
The exit multiple has new room to run.
You stop trying to do this alone.
The first move
You do not need to commit to the full play to start. You need one conversation about where the unrealized synergy lives in your platform, what a properly sequenced Phase 1 could deliver inside the next two quarters, and what the savings line could realistically support in Phase 2.
That conversation comes at no cost. The market got harder. The thesis did not. The play that closes the gap is sitting inside your contact center operation, waiting to be run.
